Medical specialists from France tagged as investigators in clinical trials studying Transitional Cell Carcinoma
Total 30 results
-
Ahmed KHALIL, MDSeen in:
- Paris, Hôpital Tenon
Trials:- NCT04678362 (Principal Investigator)
Conditions: -
Aude FlechonSeen in:
- Lyon Cedex 08, Centre Leon Bérard
- Lyon, Centre Leon Berard - Service d'Oncologie Medicale
- Lyon, Centre Leon Berard - departement d'oncologie medicale
- Lyon, Centre Leon Bérard
- Rhone, Lyon, Centre Leon Berard - departement d'oncologie medicale
- Rhône-Alpes, Lyon CEDEX 08, Centre Leon Bérard
- Rhône-Alpes, Lyon, Centre Leon Bérard
Trials:- NCT04691804 (Principal Investigator)
- NCT03706365 (Principal Investigator)
- NCT05288166 (Principal Investigator)
- NCT04601857 (Principal Investigator)
- NCT05327530 (Principal Investigator)
- NCT04678362 (Principal Investigator)
Conditions:- Metastatic Castration-Resistant Prostate Cancer (mCRPC);
- Prostate Cancer;
- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Advanced and Metastatic Urothelial Cancer;
- Locally Advanced or Metastatic Urothelial Carcinoma;
- Urothelial Carcinoma
-
Brigitte LaguerreSeen in:
- Rennes cedex, CRLCC Eugene Marquis - Service d'Oncologie médicale
- Rennes, Centre eugenie Marquis
Trials:- NCT04691804 (Principal Investigator)
- NCT05327530 (Principal Investigator)
-
Camille SERRATE, MDSeen in:
- Paris, Croix Saint-Simon Diaconesses
Trials:- NCT04678362 (Principal Investigator)
Conditions: -
Christian PfisterSeen in:
- Rouen, Hospital Center University De Rouen
- Rouen, Rouen UH
Trials:- NCT03362801 (Principal Investigator)
- NCT05902494 (Principal Investigator)
Conditions: -
Christophe TournigandSeen in:
- Creteil, Hôpital Henri Mondor - Service d'Oncologie Médicale
- Créteil, AP-HP Henri Mondor
Trials:- NCT04874207 (Principal Investigator)
- NCT05327530 (Principal Investigator)
-
Constance THIBAULT, MDSeen in:
- Ile De France, Paris, Hôpital Européen Georges Pompidou
Trials:- NCT03549715 (Principal Investigator)
Conditions: -
Damien POUESSEL, MDSeen in:
- Toulouse, IUCT
Trials:- NCT04678362 (Principal Investigator)
Conditions: -
Delphine BORCHIELLINI, MDSeen in:
- AM, Nice Cedex 2, Centre Antoine-Lacassagne
- Nice, Centre Antoine Lacassagne
Trials:- NCT05551117 (Principal Investigator)
- NCT04678362 (Principal Investigator)
- NCT05096390 (Principal Investigator)
Conditions:- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Independent Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Anal Neoplasm;
- Urothelial Carcinoma;
- Papillary Renal Cell Carcinoma Type 2
-
Elodie CoquanSeen in:
- Caen CEDEX, Centre François Baclesse - Pathologies Gynecologiques
- Caen Decex, Centre François Baclesse - Pathologies Gynecologiques
Trials:- NCT05327530 (Principal Investigator)
-
Elouen BOUGHALEM, MDSeen in:
- Angers, Institut de Cancérologie de l'Ouest
- Nantes, Institut de Cancérologie de l'Ouest
Trials:- NCT04678362 (Principal Investigator)
- NCT04327583 (Principal Investigator)
-
Eric VoogSeen in:
- Le Mans, Clinique Victor Hugo
- Le Mans, Clinique Victor Hugo - Centre Jean Bernard - Service d'Oncologie Médical
Trials:- NCT05327530 (Principal Investigator)
- NCT05848011 (Principal Investigator)
Conditions:- Locally Advanced or Metastatic Urothelial Carcinoma;
- Prostate Cancer Recurrent;
- Immunotherapy;
- Androgen-Independent Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Immune Checkpoint Inhibitor;
- Androgen-Independent Prostatic Neoplasms;
- Androgen-Insensitive Prostatic Cance;
- Inhibitory Checkpoint Molecule
-
Frederic RollandSeen in:
- Nantes, Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau
- SAINT-HERBLAIN Cedex, ICO - Site René Gauducheau - Service d'Oncologie medicale
- Saint Herblain, GSK Investigational Site
- Saint Herblain, ICO - Site René Gauducheau - Service d'Oncologie medicale
Trials:- NCT03088059 (Principal Investigator)
- NCT05386550 (Principal Investigator)
- NCT05327530 (Principal Investigator)
- NCT06062420 (Principal Investigator)
-
Guilhem RoubaudSeen in:
- Bordeaux Cedex, INSTITUT BERGONIE - Service d'Oncologie Médicale
- Bordeaux, Institut Bergonié
Trials:- NCT05327530 (Principal Investigator)
- NCT05848011 (Principal Investigator)
Conditions:- Locally Advanced or Metastatic Urothelial Carcinoma;
- Prostate Cancer Recurrent;
- Immunotherapy;
- Androgen-Independent Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Immune Checkpoint Inhibitor;
- Androgen-Independent Prostatic Neoplasms;
- Androgen-Insensitive Prostatic Cance;
- Inhibitory Checkpoint Molecule
-
Gwenaelle GravisSeen in:
- Bouches-du-Rhône, Marseille, Institut Paoli Calmettes - Hôpital de jour
- Marseille, Institut Paoli Calmettes
- Marseille, Institut Paoli Calmettes - Hôpital de jour
- Provence-Alpes-Côte-d'Azur, Marseille, Institut Paoli-Calmettes
Trials:- NCT05288166 (Principal Investigator)
- NCT04601857 (Principal Investigator)
- NCT04678362 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Advanced and Metastatic Urothelial Cancer;
- Urothelial Carcinoma
-
Hakim MAHAMMEDI, MDSeen in:
- Clermont-Ferrand, Centre Jean Perrin
Trials:- NCT04678362 (Principal Investigator)
- NCT05096390 (Principal Investigator)
-
Jean Laurent DevilleSeen in:
- Marseille Cedex 5, Hôpital de la Timone - service d'urologie
Trials:- NCT05327530 (Principal Investigator)
-
Laurence CROUZET, MDSeen in:
- Rennes, Centre Eugène Marquis
Trials:- NCT04678362 (Principal Investigator)
Conditions: -
Lionnel GeoffroisSeen in:
- Vandœuvre-lès-Nancy, Centre Regional de Lutte Contre le Cancer de Lorraine
Trials:- NCT04601857 (Principal Investigator)
Conditions: -
Louis Marie DourtheSeen in:
- Strasbourg, Clinique Sainte-Anne - Service d'Oncologie Médicale
Trials:- NCT05327530 (Principal Investigator)
-
Nadine HouedeSeen in:
- Nimes, Centre Hospitalier Universitaire de Nimes, Institut de Cancerologie du Gard
- Nîmes, CHU de Nîmes
- Nîmes, Hopital Caremeau - Service Hématologie Clinique/Oncologie Médicale
Trials:- NCT04691804 (Principal Investigator)
- NCT04048252 (Principal Investigator)
- NCT05327530 (Principal Investigator)
-
Nicolas IsambertSeen in:
- Poitiers Cedex, CHU Poitiers - Hôpital la Milétrie - service d'oncologie médicale
- Poitiers Cedex, Pôle régional de Cancérologie 2 rue de la Milèterie BP 577_Investigational Site Number :2500004
- Poitiers, CHU Poitiers
- Vienne, Poitiers, Centre Hospitalier Universitaire de Poitiers
Trials:- NCT04675827 (Principal Investigator)
- NCT05514054 (Principal Investigator)
- NCT04524689 (Principal Investigator)
- NCT05327530 (Principal Investigator)
-
Olivier HuillardSeen in:
- Paris, Hôpital Cochin - Hematologie et Oncologie Médicale
Trials:- NCT05327530 (Principal Investigator)
-
Philippe BarthelemySeen in:
- Bas-Rhin, Strasbourg, ICANS - Institut de Cancérologie de Strasbourg Europe
- Strasbourg, ICANS - Institut de Cancérologie de Strasbourg Europe
- Strasbourg, Institut de Cancérologie de Strasbourg Europe - ICANS - Service d'oncologie médicale
Trials:- NCT04601857 (Principal Investigator)
- NCT05327530 (Principal Investigator)
-
Remy DelvaSeen in:
- Angers cedex 2, ICO - Site Paul Papin - service d'oncologie medicale
Trials:- NCT05327530 (Principal Investigator)
-
Sylvain LADOIRE, MDSeen in:
- Dijon, Centre George-Francois Leclerc
Trials:- NCT04678362 (Principal Investigator)
Conditions: -
Thiery VUILLEMIN, MDSeen in:
- Besançon, CHU Jean Minjoz
Trials:- NCT04678362 (Principal Investigator)
Conditions: -
Yohann LoriotSeen in:
- Villejuif, Institut de Cancerologie Gustave Roussy
Trials:- NCT04601857 (Principal Investigator)
Conditions:
Clinical Trials on Transitional Cell Carcinoma
-
Cliniques universitaires Saint-Luc- Université...NovartisTerminatedCarcinoma Transitional CellBelgium, Luxembourg
-
Associació per a la Recerca Oncologica, SpainUnknownUrothelium Transitional Cell CarcinomaSpain, Netherlands
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingTransitional Cell Carcinoma | Metastatic Urothelial Carcinoma | Unresectable Transitional Cell CarcinomaUnited States
-
UroGen Pharma Ltd.CompletedCarcinoma, Transitional Cell | Transitional Cell Carcinoma of Renal PelvisUnited States, Israel
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedMetastatic Transitional Cell Carcinoma of the UrotheliumUnited States
-
Institute of Cancer Research, United KingdomCancer Research UKUnknownTransitional Cell Carcinoma of UreterUnited Kingdom
-
Shaheen AlaneeMerck Sharp & Dohme LLCUnknownEndoscopic Surgical Procedure | High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma | Transitional Epithelial CellsUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedTransitional Cell Carcinoma of Urinary TractNetherlands
-
Yale UniversityWithdrawnTransitional Cell CarcinomaUnited States
-
Chinese PLA General HospitalCompleted